CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company
Passage BIO, Inc.
Sign in to watch- Ticker
- PASG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822729751
- Phone
- 2678660312
- Business address
- ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-11 | Borthwick Kathleen CFO | Sale | −3,183 | $0.53 | $2K | 41,283 |
| 2025-02-10 | Borthwick Kathleen CFO | Option exercise | +8,000 | 44,466 | ||
| 2025-02-10 | Borthwick Kathleen CFO | Option exercise · Restricted Stock Unit | −8,000 | 0 | ||
| 2025-01-15 | Borthwick Kathleen CFO | Grant or award · Restricted Stock Unit | +10,000 | 10,000 | ||
| 2025-01-15 | Chou William PRESIDENT AND CEO | Grant or award · Restricted Stock Unit | +20,000 | 20,000 | ||
| 2025-01-14 | ORBIMED ADVISORS LLC 10% owner | Sale | −79,024 | $0.60 | $47K | 7,034,626 |
| 2025-01-13 | ORBIMED ADVISORS LLC 10% owner | Sale | −17,986 | $0.64 | $12K | 7,113,650 |
| 2025-01-10 | ORBIMED ADVISORS LLC 10% owner | Sale | −126,209 | $0.66 | $83K | 7,131,636 |
| 2025-01-08 | ORBIMED ADVISORS LLC 10% owner | Sale | −75,007 | $0.68 | $51K | 7,257,845 |
| 2025-01-07 | ORBIMED ADVISORS LLC 10% owner | Sale | −52,536 | $0.71 | $37K | 7,332,852 |
| 2025-01-06 | ORBIMED ADVISORS LLC 10% owner | Sale | −19,481 | $0.77 | $15K | 7,385,388 |
| 2024-12-27 | Lynx1 Capital Management LP 10% owner | Purchase | +373,645 | $0.65 | $241K | 9,256,953 |
| 2024-12-20 | ORBIMED ADVISORS LLC 10% owner | Sale | −230,321 | $0.60 | $138K | 7,404,869 |
| 2024-12-11 | ORBIMED ADVISORS LLC 10% owner | Sale | −80 | $0.80 | $64 | 7,635,190 |
| 2024-12-10 | ORBIMED ADVISORS LLC 10% owner | Sale | −8,015 | $0.80 | $6K | 7,635,270 |
| 2024-12-09 | ORBIMED ADVISORS LLC 10% owner | Sale | −54,181 | $0.84 | $46K | 7,643,285 |
| 2024-12-06 | ORBIMED ADVISORS LLC 10% owner | Sale | −20,903 | $0.82 | $17K | 7,697,466 |
| 2024-12-04 | ORBIMED ADVISORS LLC 10% owner | Sale | −76,200 | $0.79 | $60K | 7,718,369 |
| 2024-11-27 | Lynx1 Capital Management LP 10% owner | Purchase | +29,300 | $0.67 | $20K | 8,883,308 |
| 2024-11-26 | Lynx1 Capital Management LP 10% owner | Purchase | +167,055 | $0.71 | $118K | 8,854,008 |
Page 3 of 8 · 152 trades